4D pharma plc Finite-Lived Intangible Asset, Expected Amortization, Year Five

4D pharma plc Finite-Lived Intangible Asset, Expected Amortization, Year Five

4D pharma plc had Finite-Lived Intangible Asset, Expected Amortization, Year Five of $1.00 thousand as of 2020-12-31, per its 20-F/A filed 2021-04-30.

Discontinued › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity

us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive · last filed 2021-04-30

• 2020-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Five $1.00K.